Related Experiment Video
Updated: May 23, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Infectious Risk Donor Status in Uncontrolled Donation After Circulatory Death and Liver Transplantation
Chiara Lazzeri1, Paolo Antonio Grossi2, Manuela Bonizzoli3
1Regional Center for Transplant Coordination, Florence, Italy.
Insights
Uncontrolled donation after circulatory death (uDCD) donors pose a low infection risk for liver transplant recipients. Careful donor evaluation is crucial, and prompt antibiotic therapy for recipients is recommended if donor cultures are positive.
Area of Science:
- Transplantation Science
- Infectious Disease Epidemiology
- Organ Donor Management
Background:
- Limited data exist on infectious risk in uncontrolled donation after circulatory death (uDCD) donors.
- High incidence of infectious complications in out-of-hospital cardiac arrest patients necessitates understanding donor infectious risk.
Purpose of the Study:
- To assess the infectious risk profile of utilized uDCD donors.
- To evaluate the outcomes of liver transplant recipients from uDCD donors.
Main Methods:
- Consecutive utilized uDCD donors assessed between 2018 and 2024 were analyzed.
- Focus was placed on the infectious risk profile of donors and the outcomes in liver transplant recipients.
Main Results:
- 16 out of 52 uDCDs had positive blood cultures, predominantly Gram-positive bacteria (88%).
- These microorganisms were deemed contaminants and were not isolated in recipients.
- No donor-related infections were observed in the 24 liver transplant recipients.
Conclusions:
- uDCD donors present a low risk of infection transmission to liver transplant recipients.
- Systematic donor evaluation is essential due to time constraints and urgent procedures.
- Prompt reporting of positive donor cultures and timely antibiotic therapy for recipients are recommended.
Backgrounds:
Few data are so far available concerning the infectious risk donor profile in uncontrolled donation after circulatory death (uDCDs), despite the high incidence of infectious complications observed in out-of-hospital cardiac arrest patients.
Methods:
We assessed the donor risk profile in utilized uDCD donors consecutively assessed from 2018 to 2024, focusing on the outcome of liver transplant recipients.
Results:
Fifty-two consecutive utilized uDCDs were included. In 16 uDCDs, blood cultures were positive. In all these cases, Gram-positive bacteria were observed, mainly cocci (14/16, 88%). These microorganisms were considered contaminants. None of these microorganisms were isolated in recipients. No donor-related infection was detected in the 24 liver transplant recipients.
Conclusions:
According to our results, uDCDs show a low risk of infection transmission to the recipients. Nevertheless, a careful and systematic approach to donor evaluation should be pursued and implemented, considering the restricted time frame for assessment and the urgent procedures performed, considering the characteristics of uDCD (comprising the performance of an urgent procedure). Transplant coordinators should promptly report culture positivity in one of the collected samples, thus allowing the timely initiation of antibiotic therapy in the recipients. In uDCD donors, some information on infectious risk may be lacking, considering the limited time and that a urine culture may not be feasible since these donors may be anuric.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

